This is an NIH/NIMH research grant for early-stage clinical trials of drugs or neuromodulatory devices that treat mental disorders, and every application must test how the intervention works mechanistically, not just whether it helps. It fits small biotech, pharma, and device companies plus research institutions that can run clinical trials. Retailers, restaurants, contractors, and any business wanting general operating money should not bother.
- Best for
- Small biotech or pharma companies developing drugs or devices for mental disorders, Clinical research teams at universities and hospitals, Nonprofits running mental health clinical trials, Contract research organizations with experimental therapeutics expertise
- Not for
- Retail, construction, finance, education, and other businesses outside clinical mental health research, Companies without the capacity to run a clinical trial testing mechanism of action, Organizations seeking general operating or service-delivery funding
These are our matcher’s estimates for a typical business in each industry. A real match depends on your size, your state and what you need the money for — check your own fit.